Alpha-9 Theranostics attracts C$11m Series A led by Longitude

Vancouver-based radiopharmaceutical company Alpha-9 Theranostics has secured C$11 million in a Series A financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this